Navigation Links
ClearScript Offers Innovative Medication Therapy Management Program to Employee Health Plans
Date:3/21/2008

Landmark Study Cites 12-to-1 Return on Investment

MINNEAPOLIS, March 21 /PRNewswire/ -- ClearScript today announced that it is introducing Medication Therapy Management (MTM) as a benefit option to employer health plans across the US. A landmark study published in the Journal of the American Pharmacists Association cites a 12-to-1 return on investment for patients receiving MTM services through improved health outcomes and lower total health care expenditures.

"We are pleased to move MTM from successful pilot stage to a fully-fledged service available directly to employers," said Mike Reinke, ClearScript President. "MTM meets an urgent need for employers and health plan managers who are scrambling to contain plan costs while optimizing employee health and satisfaction."

ClearScript will provide MTM services through a network of specially trained pharmacists who provide 1-on-1 consultations with patients struggling with chronic diseases such as diabetes, high cholesterol and hypertension. Together with the patients' physicians and other healthcare providers, MTM pharmacists help patients solve medication-related problems, adhere to drug regimens and achieve optimal health outcomes.

ClearScript's MTM service model was developed collaboratively by Fairview Health Services and the University of Minnesota College of Pharmacy. Study results are documented in the March, 2008 issue of the Journal of the American Pharmacists Association in an article entitled Clinical and Economic Outcomes of Medication Therapy Management Services: The Minnesota Experience (Isetts, et al. J Am Pharm Assoc. 2008;48(2):203-211). The article reports on the effects of face-to-face MTM services in 285 patients with multiple medical conditions and complex drug therapies compared against a similar group of 252 patients who did not receive MTM services. Patients receiving MTM services demonstrated significant improvement in drug therapy goals achieved, dru
'/>"/>

SOURCE ClearScript
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Fort Dodges Mosquito Shot Offers Convenient Protection Against Dangerous Mosquito-Borne Illnesses
2. Make Your Mammogram a Positive Experience: Author Offers Guidelines and Tips to Change Womens Negative Attitudes Toward Mammograms
3. NARSADs 5th Annual Mission Possible Symposium Offers Insight to PTSD and Other Mental Illnesses
4. Stem Cell Technology Offers Promise of Huge Savings for Drug Developers
5. Metabolic Cardiologist Offers New Hope for Women With Heart Disease
6. Waters Offers U.S. Water Authorities Complimentary Drinking Water Testing for the Presence of Pharmaceuticals
7. SearchMedica Offers Medical Professionals Six New Specialized Clinical Web Searches
8. Peapod Offers First Ever Virtual Nutritionist
9. Ekahau Offers Clear Visibility Into Real-Time Location Tracking With Ekahau Vision
10. California Study Offers New Perspective on Relationship Between Staffing Ratios and Patient Safety
11. Penn research offers road map to safer pain control, cost savings during colonoscopies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...TLAKE, Texas, Dec. 4 Mid... today announced that it has opened its,administr...mpany,s Germantown,facility will continue to hous...leBrook,s research and development group. The new... expected to house up to 60 employees as MiddleBro...
(Date:12/4/2008)... ARBOR, Mich., Dec. 4 BAPTIST HEAL...rk., and the state,s largest health system, has,e...om Thomson Reuters -- a,solution that enabled the...al,interventions and save more than $1 million. ,...ittle Rock campus show that,CareFocus prompts app...
(Date:12/4/2008)...e effects similar to those seen with standard dose...AY, Dec. 4 (HealthDay News) -- A high dose of the ...for patients with previously untreated acute myelo...sponsored by the U.S. National Cancer Institute (N...ne marrow. This study included 633 patients, aged ...
(Date:12/4/2008)...ctronic AIDS Quilt Unites Leaders of Virginia, Mar... Dec. 4 Nationally, Was...e living with AIDS in D.C., 82 percent are African...this crisis in D.C. and the South, today,s Living ...ity brought together the leaders of the Virginia,...
Breaking Medicine News(10 mins):Health News:Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas 2Health News:Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas 3Health News:Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas 4Health News:BAPTIST HEALTH Uses Real-Time Clinical Surveillance from Thomson Reuters to Lower Costs and Improve Quality in the Pharmacy 2Health News:BAPTIST HEALTH Uses Real-Time Clinical Surveillance from Thomson Reuters to Lower Costs and Improve Quality in the Pharmacy 3Health News:Higher Chemo Drug Dose Prolongs Lives of Leukemia Patients 2Health News:Southern AIDS Living Quilt Raises Awareness in Washington, D.C. 2Health News:Southern AIDS Living Quilt Raises Awareness in Washington, D.C. 3
...titute of Medical Research (MIMR) have developed a...ich allowed scientists// to monitor preterm babies...nd in Australia, helped doctors to monitor continu...rain oxygen levels of a preterm babies. Scientis...
...inian doctor and five Bulgarian nurses who have be...as resumed //in the Libyan capital, Tripoli. Thre...children as prosecution witnesses in a Libyan cour...women as the nurses who knowingly infected 400 chi...
...cted by Stephanie Chiuve it was found that a healt... ailments//. U.S. researchers stated that patient...n benefit if they alter their lifestyle. It was d...an reduce their heart problems by 57% if they main...
...besity-related risk factors have indicated that mo...ence of health risks// like hypertension, diabetes...of obesity played a main role in predisposing wome...rchers reported from an observational study. Obes...
Other Medicine News:Health News:Preterm Babies Benefited from a New NI Spectroscopy 2Health News:Obese Women are more likely to suffer from Major Health Risks 2Health News:Obese Women are more likely to suffer from Major Health Risks 3
(Date:12/3/2008)...LSBAD, Calif., Dec. 3 Is...ced today that OncoGenex Pharmaceuticals, Inc.,pr... Phase 2 clinical trial of,OGX-011 in combination...,compared to docetaxel and prednisone alone ("the...atic castrate resistant prostate cancer. The curr...
(Date:12/2/2008)...CAGO, Dec. 3 Breast-spe...tection of cancers not found on mammograms or by,...y at the annual meeting of,the Radiological Socie...ntify the most difficult to detect breast cancer-i...el F. Brem, M.D., professor of,radiology and dire...
(Date:12/2/2008)...KIE, Ill., Dec. 2 Horizon Therapeu...mpany, today announced that two pivotal,Phase 3 t...candidate, HZT-501,met all primary endpoints. HZ...n product containing ibuprofen and famotidine, dem...n the incidence of non-steroidal,anti-inflammator...
(Date:12/1/2008)...KVILLE, Md., Dec. 1 Vand...ublication in The Lancet , one of the world,s lea...of its novel circadian regulator, experimental com...ajaratnam et al(1) is entitled "Melatonin agonist ... sleep-time shift: two randomised controlled multi...
Breaking Medicine Technology:Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 2Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 3Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 4New Breast Imaging Technology Targets Hard-to-Detect Cancers 2New Breast Imaging Technology Targets Hard-to-Detect Cancers 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Generalist bacteria discovered in coastal waters may be more flexible than known before 2024 1Generalist bacteria discovered in coastal waters may be more flexible than known before 2024 2Notch ing glucose into place 10173 1Notch ing glucose into place 10173 2American Society for Dermatologic Surgery Supports Current Labeling of Allergans Botox 28R 29 Products 10170 1American Society for Dermatologic Surgery Supports Current Labeling of Allergans Botox 28R 29 Products 10170 2Making the Most Out of Your Doctors Visit 10166 1Making the Most Out of Your Doctors Visit 10166 2
... Ohio, June 08, 2007,/PRNewswire-FirstCall/ --Eura...ibrosis Society Annual,Meeting. ...-- Exocrine pancreatic insufficiency (EPI) is a,de...roduced by,the pancreas that can result from a num...is, chronic pancreatitis, and , , pancreatic...
...ents Taking Trexima were Migraine Free,Compared to...ew data from two large,trials show that Trexima, w...placebo in eliminating all traditional migraine,sy...ks with just,one tablet. The findings will be pres...ng of the American Headache Society. , In addition...
Other Medicine Technology:Eurand to Present Zentase Phase III Data 2Eurand to Present Zentase Phase III Data 3Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free,Response Across Multiple Attacks 2Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free,Response Across Multiple Attacks 3Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free,Response Across Multiple Attacks 4
Aplicare's Saturated Swabsticks are packaged in easy open, single-use foil-laminated pouches. Each 4 inch Swabstick is saturated with precisely the correct amount of solution. Each package is termina
Aplicare's saturated swabsticks are packaged in easy open, single use, foil-laminated pouches. Each 4 inch swabstick is saturated with precisely the correct amount of Povidone Iodine gel. The Gel Swa
An Antiseptic Antibacterial that does not contain Alcohol. In less than 30 seconds, destroys over 99% of bacteria. Can be used for cleansing of minor wounds, burns, cuts, scrapes and for disinfection
All Povidone Iodine 'Prep' solutions are effective for skin and mucous membrane preparation prior to surgical procedures. All Povidone Iodine 'Scrub' solutions are antimicrobial solutions with surfac
Medicine Products: